ライフサイエンスコーパス: delta9-tetrahydrocannabinol

1 nce accuracy was significantly reduced after Delta9-tetrahydrocannabinol.

2 blished global toxicity threshold of 1 ug/kg Delta9-tetrahydrocannabinol.

3 for prediction for cocaine, amphetamine, and Delta9-tetrahydrocannabinol.

4 a9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol.

5 he most common cannabinoid compound type was Delta9-tetrahydrocannabinol (54 699 [63.30%]).

6 Delta9-Tetrahydrocannabinol administration enhanced acti

7 Delta9-Tetrahydrocannabinol also attenuated the normal t

8 (THC) and its major metabolites, 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-

9 f nabiximols (maximum daily dose, 86.4 mg of Delta9-tetrahydrocannabinol and 80 mg of cannabidiol) or

10 e, and generate human exposure estimates for Delta9-tetrahydrocannabinol and cannabidiol.

11 delta9-Tetrahydrocannabinol and endogenous cannabinoids

12 h as the nucleus accumbens after exposure to Delta9-tetrahydrocannabinol, but less is known about can

13 stress, rats self-administered cannabinoids (delta9-tetrahydrocannabinol + cannabidiol; THC + CBD) fo

14 formed on three common cannabinoids, namely, Delta9-tetrahydrocannabinol, cannabidiol, and cannabinol

15 ociated with users' urinary 11-nor-9-carboxy-Delta9-tetrahydrocannabinol concentrations at study entr

16 odies with high affinity and specificity for delta9-tetrahydrocannabinol could be valuable immunophar

17 cannabis, which are attributed to action of Delta9-tetrahydrocannabinol (Delta(9)-THC), a cannabis c

18 Chronic Delta9-tetrahydrocannabinol (Delta9-THC) administration

19 annabis sativa and its principal components, Delta9-tetrahydrocannabinol (Delta9-THC) and cannabidiol

20 evaluated the isolated impact of caffeine on Delta9-tetrahydrocannabinol (Delta9-THC) effects as well

21 Commercial products contained Delta9-tetrahydrocannabinol (Delta9-THC) equivalents ran

22 Delta9-Tetrahydrocannabinol (delta9-THC) fails to inhibi

23 onic treatment of SIV-infected macaques with Delta9-tetrahydrocannabinol (Delta9-THC) increased survi

24 infected macaques, chronic administration of Delta9-tetrahydrocannabinol (Delta9-THC) inhibited viral

25 Delta9-tetrahydrocannabinol (delta9-THC) is an effective

26 Delta9-tetrahydrocannabinol (Delta9-THC) is the principa

27 used to examine the effects of estrogen and delta9-tetrahydrocannabinol (delta9-THC) on learning and

28 Mice were treated with escalating doses of Delta9-tetrahydrocannabinol (Delta9-THC) or R+-[2,3-dihy

29 primary psychoactive ingredient in cannabis, Delta9-tetrahydrocannabinol (Delta9-THC), affects the br

30 e major psychoactive component of marijuana, Delta9-tetrahydrocannabinol (Delta9-THC), are presented.

31 Delta9-Tetrahydrocannabinol (Delta9-THC), the major psyc

32 and an improvement in affinity for (-)-trans-delta9-tetrahydrocannabinol (delta9-THC).

33 times attenuate or exacerbate the effects of Delta9-tetrahydrocannabinol (Delta9-THC).

34 osure to the most abundant phytocannabinoid, Delta9-tetrahydrocannabinol (Delta9-THC).

35 The main active chemical in marijuana is delta9-tetrahydrocannabinol (delta9-THC); hence, monoclo

36 centres with oral cannabis extract (n=211), Delta9-tetrahydrocannabinol (Delta9-THC; n=206), or plac

37 (-)-Delta9-Tetrahydrocannabinol ((-)-Delta9-THC) is the majo

38 led or high-potency cannabis (>=10% or 10 mg Delta9-tetrahydrocannabinol [Delta9-THC]) for medical pu

39 Delta9-Tetrahydrocannabinol enhanced WM activity network

40 principal bioactive component of marijuana, delta9-tetrahydrocannabinol, have been used for thousand

41 Delta9-Tetrahydrocannabinol increased psychotic symptoms

42 an dried herbs, which usually contain higher Delta9-tetrahydrocannabinol levels, may have shifted ove

43 perimentally induced higher cannabinoid [(-)-Delta9-tetrahydrocannabinol] levels constrain preimplant

44 (CB) receptor agonism using R(+)-WIN 55,212, delta9-tetrahydrocannabinol, methanandamide and JWH-133

45 gn, investigating effects of the eCB agonist Delta9-tetrahydrocannabinol on WM function in 17 healthy

46 Both cannabinoid agonists WIN 55,212-2 and delta9-tetrahydrocannabinol shortened the modal response

47 The plant-derived cannabinoids delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD)

48 Delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD)

49 Levels of the cannabis biomarker Delta9-tetrahydrocannabinol (THC) and its major metaboli

50 Anandamide (AEA) and delta9-tetrahydrocannabinol (THC) are endogenous and exo

51 Placental transfer of Delta9-tetrahydrocannabinol (THC) during pregnancy has t

52 ermining whether a driver is impaired due to Delta9-tetrahydrocannabinol (THC) exposure.

53 ylamphetamine (MDEA), morphine, cocaine, and Delta9-tetrahydrocannabinol (THC) from a single blood sp

54 The neural mechanisms and durability of Delta9-tetrahydrocannabinol (THC) impact on threat proce

55 evaluate the effects of repeated exposure to Delta9-tetrahydrocannabinol (THC) in a mouse model of su

56 Chronic exposure to Delta9-tetrahydrocannabinol (THC) induces tolerance to c

57 we examined the acute and delayed effects of Delta9-tetrahydrocannabinol (THC) intoxication on suscep

58 elated positively with creatinine-normalized Delta9-tetrahydrocannabinol (THC) levels.

59 ating effects of the endocannabinoid agonist Delta9-tetrahydrocannabinol (THC) on executive function

60 examined the effects of repeated exposure to Delta9-tetrahydrocannabinol (THC) on performance of spat

61 We aimed to investigate the effect of oral Delta9-tetrahydrocannabinol (THC) on subjective and meta

62 ear whether adolescent cannabis exposure and Delta9-tetrahydrocannabinol (THC) potency specifically p

63 ation of cannabinoid CB1 receptors (CB1R) by delta9-tetrahydrocannabinol (THC) produces a variety of

64 n of the psychoactive component of cannabis, delta9-tetrahydrocannabinol (THC), activated cerebellar

65 ), as well as exogenous cannabinoids such as Delta9-tetrahydrocannabinol (THC), are mediated by two s

66 ometry (UHPLC-MS/MS) for analysis of urinary Delta9-tetrahydrocannabinol (THC), cannabidiol and canna

67 The primary cannabinoid in cannabis, Delta9-tetrahydrocannabinol (THC), causes intoxication a

68 after chronic exposure to vehicle solution, Delta9-tetrahydrocannabinol (THC), or the cannabinoid ag

69 Here we report that Delta9-tetrahydrocannabinol (THC), the major psychoactiv

70 Cannabinoid 1 receptors, the main target of Delta9-tetrahydrocannabinol (THC), the primary intoxicat

71 Delta9-tetrahydrocannabinol (THC), the principal bioacti

72 Delta9-Tetrahydrocannabinol (THC), which is the main bio

73 aised medical concerns, primarily related to Delta9-tetrahydrocannabinol (THC), which readily crosses

74 rijuana, and the psychotropic cannabinoid (-)Delta9-tetrahydrocannabinol (THC).

75 of benzoylecgonine (BE) and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol (THC-COOH) were shown to be

76 vation are mimicked by administration of (-)-Delta9-tetrahydrocannabinol (THC; the major psychoactive

77 removed hemp (ie, cannabis containing <0.3% Delta9-tetrahydrocannabinol [THC]) from the US controlle

78 binoid receptors also mediate the effects of Delta9-tetrahydrocannabinol, the primary psychoactive in

79 ed by urine immunoassay for 11-nor-9-carboxy-Delta9-tetrahydrocannabinol using frozen stored urine sa

80 Delta9-tetrahydrocannabinol was detected in liver, kidne

81 We additionally found that Delta9-tetrahydrocannabinol, which has been shown to att